Medutech to market ETView's VivaSight airway management platform

NewsGuard 100/100 Score

ETView Medical, Ltd. (TASE: ETVW) announced today that it has entered into a distribution agreement with Medutech Co., Ltd. (Medutech). The agreement enables Medutech to market ETView's VivaSight™ airway management platform (previously known as TVT™), combining an airway ventilation tube with integrated continuous high resolution airway imaging for patient airway control and lung isolation capability, in Mexico for a period of 2 years. Other terms were not disclosed.

“VivaSight™ is currently being distributed across Europe, Asia and the United States. VivaSight™ provides best-in-class airway management solutions for sophisticated thoracic surgical procedures requiring lung isolation.”

William Edelman, CEO of ETView Medical, commented, "We are excited to add Medutech to our expanding distributor network." Mr. Edelman continued, "VivaSight™ is currently being distributed across Europe, Asia and the United States. VivaSight™ provides best-in-class airway management solutions for sophisticated thoracic surgical procedures requiring lung isolation." On March 19, 2012, ETView announced a distribution agreement with Amphar b.v., a medical device and generic pharmaceutical distributor in the Netherlands.

On March 12, 2012, ETView announced KFDA Pre-Market Clearance for the VivaSight™‐SL line of Innovative Airway Devices.

On March 5, 2012 and February 6, 2012, ETView announced filing of a Technical File, initiating CE Registration and a Pre‐Marketing Notification Application (510(k)) with the FDA for the Viva™ EB Line of Innovative Endobronchial Blockers. On December 12, 2011, ETView announced that the company filed a Pre-Marketing Notification Application (510(k)) with the FDA for the VivaSight™ DL Airway Management System. VivaSight™-DL1 is a proprietary, single-use disposable medical device, consisting of a dual lumen airway ventilation tube with an integrated continuous high resolution video airway imaging system permitting airway control and lung isolation during certain surgical procedures.

On February 7, and February 2, 2012, ETView announced distribution agreements with NeuroMed Ltd. (NeuroMed), a surgical products sales and distribution company based in St. Petersburg, Russia, and State of the Art (SOTA) Medical Products, Inc., a specialty surgical products sales and distribution company, based in Cedar Grove, New Jersey.

Source:

 Medutech Ltd. 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Genetic and lifestyle factors linked to brain network aging, study reveals